Lymphoproliferative Disorders

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL

Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies

Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL

Administration of T Lymphocytes for Prevention of Relapse of Lymphomas

Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity

Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies

Clonal Hematopoiesis of Immunological Significance

Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation

Feasibility of a Multi-omics Platform for Hematological Malignancies

Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021)

DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.

Virtual Rehabilitation for Cancer Survivors

Pathogenesis of Hematologic Malignancies

Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms

DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers

DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.